» Articles » PMID: 15144954

Nucleolar Protein NPM Interacts with HDM2 and Protects Tumor Suppressor Protein P53 from HDM2-mediated Degradation

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2004 May 18
PMID 15144954
Citations 182
Authors
Affiliations
Soon will be listed here.
Abstract

Nucleophosmin (NPM, B23) is an abundant nucleolar phosphoprotein involved in ribosome biogenesis, and interacts with tumor suppressor proteins p53 and Rb. Here we show that NPM is a UV damage response protein that undergoes nucleoplasmic redistribution and regulates p53 and HDM2 levels and their interaction. By utilizing RNAi approaches and analyses of endogenous and ectopically expressed proteins, we demonstrate that NPM binds HDM2 and acts as a negative regulator of p53-HDM2 interaction. Viral stress, enforced by expression of Kaposi's sarcoma virus K cyclin, causes NPM redistribution, K cyclin-NPM association, and p53 stabilization by dissociation of HDM2-p53 complexes. The results demonstrate novel associations of HDM2 and K cyclin with NPM and implicate NPM as a crucial controller of p53 through inhibition of HDM2.

Citing Articles

Stress sensing and response through biomolecular condensates in plants.

Peng J, Yu Y, Fang X Plant Commun. 2024; 6(2):101225.

PMID: 39702967 PMC: 11897469. DOI: 10.1016/j.xplc.2024.101225.


Functions of the native NPM1 protein and its leukemic mutant.

Falini B, Sorcini D, Perriello V, Sportoletti P Leukemia. 2024; 39(2):276-290.

PMID: 39690184 DOI: 10.1038/s41375-024-02476-4.


Cytochrome prompts the recruitment of its nuclear partners SET/TAF-Iβ and NPM1 into biomolecular condensates.

Casado-Combreras M, Velazquez-Campoy A, Martinho M, Belle V, De la Rosa M, Diaz-Moreno I iScience. 2024; 27(8):110435.

PMID: 39108706 PMC: 11301353. DOI: 10.1016/j.isci.2024.110435.


How snoRNAs can contribute to cancer at multiple levels.

Zacchini F, Barozzi C, Venturi G, Montanaro L NAR Cancer. 2024; 6(1):zcae005.

PMID: 38406265 PMC: 10894041. DOI: 10.1093/narcan/zcae005.


Platinum-based drugs induce phenotypic alterations in nucleoli and Cajal bodies in prostate cancer cells.

Batnasan E, Karkkainen M, Koivukoski S, Sadeesh N, Tollis S, Ruusuvuori P Cancer Cell Int. 2024; 24(1):29.

PMID: 38218884 PMC: 10790272. DOI: 10.1186/s12935-023-03205-0.